MDM2 and leukemia: To determine the effect of Hinokiflavone on MDM2 and p53 ubiquitination in the cell, the proteasome inhibitor MG132 was employed to enrich the cellular ubiquitinated MDM2 and p53 using a leukemia cell line AML-2.